The First Dipeptide Mimetic of Neurotrofin-3: Design and Pharmacological Properties.
Gudasheva TA, Sazonova NM, Tarasiuk AV, Logvinov IO, Antipova TA, Nikiforov DM, Povarnina PY, Seredenin SB · 2022 · Doklady. Biochemistry and biophysics
What does this source report?
GTS-301 activated TrkC and TrkB, protected HT-22 cells in injury assays and showed antidepressant-like activity in a mouse forced-swim experiment.
- Population and setting
- Cell cultures and mice
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- English indexed abstract; original language: eng
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Preclinical findings do not establish human benefit or safety.
- Indexed abstract reviewed; full methods and independent replication require appraisal.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Abstract reviewed
Source access and review scope
Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.
Recorded source-check date: 2026-10-05. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Gudasheva TA, Sazonova NM, Tarasiuk AV, Logvinov IO, Antipova TA, Nikiforov DM, Povarnina PY, Seredenin SB. The First Dipeptide Mimetic of Neurotrofin-3: Design and Pharmacological Properties. Doklady. Biochemistry and biophysics 2022.
Molekul research summary: https://molekul.io/research/rp-36038682. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry